Antiviral Effect of Budesonide against SARS-CoV-2

Treatment options for COVID-19, a disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, are currently severely limited. Therefore, antiviral drugs that efficiently reduce SARS-CoV-2 replication or alleviate COVID-19 symptoms are urgently needed. Inhaled glucocorti...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinen, Natalie, Meister, Toni Luise, Klöhn, Mara, Steinmann, Eike, Todt, Daniel, Pfaender, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310374/
https://www.ncbi.nlm.nih.gov/pubmed/34372616
http://dx.doi.org/10.3390/v13071411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310374/
https://www.ncbi.nlm.nih.gov/pubmed/34372616
http://dx.doi.org/10.3390/v13071411

Ejemplares similares